StockIQ.techCardinal Health, Inc. (CAH) Stock Analysis
Free AI-powered analysis and research for Cardinal Health, Inc. stock
Sector: Healthcare
CAH snapshot
Data as of 3 Nov 2026 close. Updated daily.
Cardinal Health, Inc. scores 44/100 on StockIQ's model, which reads as mixed signals overall. The price is above its 200-day average and at 93% of its 52-week range, up 33.9% over the past year. Latest reported figures show a profit margin of 0.7% and revenue growth of +5.8%.
What is driving the score
- Strong Uptrend: +12
- MACD Bearish: -8
- High P/E (34.7): -10
- Weak Profit Margin (0.7%): -8
- Low Liquidity (0.88 Current Ratio): -10
- Low P/B (-20.28): +5
- Strong Long-term Uptrend: +8
- Strong Momentum (+33.9% over 1 year): +8
- Low Volume (0.3x): -3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full CAH report
Cardinal Health, Inc. (CAH) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze CAH Now →📰 Latest Update
What Analyst Projections for Key Metrics Reveal About Cardinal (CAH) Q1 Earnings
Mon, November 2, 2026 at 1:15 PM UTC 3 min read
Analysts project that Cardinal Health (CAH) will report quarterly earnings of $2.92 per share, reflecting a 14.5% year-over-year increase, with revenues expected to reach $66.96 billion, up 4.6% from the previous year. Key revenue segments are forecasted to show growth, including Pharmaceutical and Specialty Solutions at $61.90 billion and Other at $1.78 billion. Cardinal shares have risen 9.7% over the past month, while the Zacks Rank for CAH is #3 (Hold), indicating it may closely follow market performance.